$568 Million is the total value of Redmile Group, LLC's 49 reported holdings in Q2 2013. The portfolio turnover from Q1 2013 to Q2 2013 was 78.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALGN | Buy | ALIGN TECHNOLOGY INC | $38,839,000 | +43.6% | 1,048,559 | +29.9% | 6.84% | +37.8% |
| ONXX | Sell | ONYX PHARMACEUTICALS INC | $34,205,000 | -4.2% | 393,981 | -2.0% | 6.03% | -8.1% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $31,841,000 | +123.3% | 475,377 | -4.4% | 5.61% | +114.4% |
| CAH | Buy | CARDINAL HEALTH INC | $27,565,000 | +903.5% | 584,000 | +784.8% | 4.86% | +863.7% |
| HCA | Buy | HCA HOLDINGS INC | $26,443,000 | +99.0% | 733,300 | +124.2% | 4.66% | +91.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $23,960,000 | +34.0% | 539,994 | +0.9% | 4.22% | +28.6% |
| CELG | New | CELGENE CORP | $23,501,000 | – | 200,900 | +100.0% | 4.14% | – |
| ARIA | Buy | ARIAD PHARMACEUTICALS INC | $22,337,000 | +51.2% | 1,277,109 | +56.3% | 3.94% | +45.2% |
| ARRY | Buy | ARRAY BIOPHARMA INC | $21,653,000 | -6.6% | 4,769,368 | +1.0% | 3.82% | -10.4% |
| IPXL | Buy | IMPAX LABORATORIES INC | $19,162,000 | +89.6% | 961,100 | +46.8% | 3.38% | +82.0% |
| NUVA | Buy | NUVASIVE INC | $18,939,000 | +437.6% | 763,992 | +362.1% | 3.34% | +415.8% |
| PODD | Sell | INSULET CORP | $18,007,000 | +3.3% | 573,300 | -15.0% | 3.17% | -0.9% |
| HTWR | Sell | HEARTWARE INTL INC | $15,439,000 | -7.5% | 162,325 | -14.0% | 2.72% | -11.2% |
| THC | New | TENET HEALTHCARE CORP | $14,577,000 | – | 316,200 | +100.0% | 2.57% | – |
| BKD | Buy | BROOKDALE SR LIVING INC | $14,449,000 | +38.3% | 546,500 | +45.9% | 2.55% | +32.7% |
| REGN | New | REGENERON PHARMACEUTICALS | $13,718,000 | – | 61,000 | +100.0% | 2.42% | – |
| ZBH | New | ZIMMER HLDGS INC | $13,332,000 | – | 177,900 | +100.0% | 2.35% | – |
| VHS | Sell | VANGUARD HEALTH SYS INC | $13,314,000 | +22.0% | 641,955 | -12.5% | 2.35% | +17.2% |
| GMED | Buy | GLOBUS MED INCcl a | $11,814,000 | +47.6% | 700,700 | +28.5% | 2.08% | +41.6% |
| MRK | New | MERCK & CO INC NEWcall | $11,613,000 | – | 250,000 | +100.0% | 2.05% | – |
| MODN | New | MODEL N INC | $11,320,000 | – | 484,600 | +100.0% | 2.00% | – |
| CPHD | Buy | CEPHEID | $10,977,000 | +73.4% | 318,900 | +93.3% | 1.93% | +66.4% |
| CMRX | New | CHIMERIX INC | $10,927,000 | – | 450,800 | +100.0% | 1.92% | – |
| CERS | Buy | CERUS CORP | $10,720,000 | +58.9% | 2,425,400 | +58.9% | 1.89% | +52.6% |
| AGN | New | ALLERGAN INC | $10,701,000 | – | 127,027 | +100.0% | 1.89% | – |
| CSU | Buy | CAPITAL SR LIVING CORP | $10,105,000 | +48.3% | 422,800 | +63.9% | 1.78% | +42.4% |
| TRNX | New | TORNIER N V | $9,609,000 | – | 549,100 | +100.0% | 1.69% | – |
| WAT | New | WATERS CORP | $7,970,000 | – | 79,664 | +100.0% | 1.40% | – |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $7,767,000 | -19.2% | 580,500 | -26.6% | 1.37% | -22.4% |
| WOOF | New | VCA ANTECH INC | $7,253,000 | – | 278,000 | +100.0% | 1.28% | – |
| CYBX | Sell | CYBERONICS INC | $7,228,000 | -7.1% | 139,100 | -16.4% | 1.27% | -10.8% |
| ABMD | New | ABIOMED INC | $7,033,000 | – | 326,189 | +100.0% | 1.24% | – |
| OREX | Sell | OREXIGEN THERAPEUTICS INC | $6,958,000 | -17.4% | 1,190,440 | -11.5% | 1.23% | -20.7% |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $6,200,000 | – | 2,450,580 | +100.0% | 1.09% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $5,531,000 | -12.4% | 2,373,687 | +19.2% | 0.98% | -15.9% |
| BSTC | BIOSPECIFICS TECHNOLOGIES CO | $4,870,000 | -8.5% | 312,152 | 0.0% | 0.86% | -12.2% | |
| CCXI | New | CHEMOCENTRYX INC | $3,607,000 | – | 255,100 | +100.0% | 0.64% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $3,570,000 | – | 38,700 | +100.0% | 0.63% | – |
| CYCC | Buy | CYCLACEL PHARMACEUTICALS INC | $3,179,000 | -1.5% | 1,077,465 | +86.6% | 0.56% | -5.6% |
| KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $2,979,000 | +13.1% | 110,118 | +1.8% | 0.52% | +8.7% |
| New | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $2,859,000 | – | 3,000,000 | +100.0% | 0.50% | – | |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $296,000 | +1.0% | 6,500 | 0.0% | 0.05% | -3.7% | |
| IBB | New | ISHARES TRnasdq bio indx | $261,000 | – | 1,500 | +100.0% | 0.05% | – |
| ABT | New | ABBOTT LABS | $251,000 | – | 7,200 | +100.0% | 0.04% | – |
| SLXP | Sell | SALIX PHARMACEUTICALS INC | $218,000 | -98.9% | 3,300 | -99.1% | 0.04% | -98.9% |
| UNH | Sell | UNITEDHEALTH GROUP INC | $210,000 | -26.6% | 3,200 | -36.0% | 0.04% | -28.8% |
| IDIX | IDENIX PHARMACEUTICALS INC | $109,000 | +1.9% | 30,200 | 0.0% | 0.02% | -5.0% | |
| XNPT | New | XENOPORT INC | $62,000 | – | 12,500 | +100.0% | 0.01% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $55,000 | -99.5% | 50,000 | -98.9% | 0.01% | -99.5% |
| EXEL | Exit | EXELIXIS INC | $0 | – | -22,300 | -100.0% | -0.02% | – |
| HMA | Exit | HEALTH MGMT ASSOC INC NEWcl a | $0 | – | -12,120 | -100.0% | -0.03% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -13,400 | -100.0% | -0.03% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -9,700 | -100.0% | -0.04% | – |
| IHF | Exit | ISHARES TRdj health care | $0 | – | -3,700 | -100.0% | -0.05% | – |
| GIVN | Exit | GIVEN IMAGING | $0 | – | -25,000 | -100.0% | -0.08% | – |
| Exit | ACCURAY INCnote 3.750% 8/0 | $0 | – | -500,000 | -100.0% | -0.08% | – | |
| GWAY | Exit | GREENWAY MED TECHNOLOGIES IN | $0 | – | -159,815 | -100.0% | -0.47% | – |
| ARTC | Exit | ARTHROCARE CORP | $0 | – | -121,978 | -100.0% | -0.78% | – |
| Exit | EXELIXIS INCnote 4.250% 8/1 | $0 | – | -5,000,000 | -100.0% | -0.91% | – | |
| TSRX | Exit | TRIUS THERAPEUTICS INC | $0 | – | -778,250 | -100.0% | -0.98% | – |
| OPTR | Exit | OPTIMER PHARMACEUTICALS INC | $0 | – | -755,000 | -100.0% | -1.65% | – |
| GRFS | Exit | GRIFOLS S Asp adr rep b nvt | $0 | – | -425,700 | -100.0% | -2.27% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -252,000 | -100.0% | -2.31% | – |
| SIRO | Exit | SIRONA DENTAL SYSTEMS INC | $0 | – | -178,800 | -100.0% | -2.42% | – |
| CPTS | Exit | CONCEPTUS INC | $0 | – | -581,572 | -100.0% | -2.58% | – |
| PFE | Exit | PFIZER INC | $0 | – | -667,100 | -100.0% | -3.53% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -388,600 | -100.0% | -4.56% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -726,540 | -100.0% | -6.53% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -700,000 | -100.0% | -12.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.